Anticancer effect of photodynamic therapy with hexenyl ester of 5-aminolevulinic acid in oral squamous cell carcinoma

Head and Neck

Volumn 32, Issue 9, 2010, Pages 1136-1142

  Moon, Yeon Hee ^a   Park, Jong Hwan ^a   Kim, Soo A ^b   Lee, Jee Bum ^c   Ahn, Sang Gun ^a   Yoon, Jung Hoon ^a  

^a Chosun University   (South Korea)

^b Dongguk University   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

5 aminolevulinic acid (ALA); apoptosis; human oral squamous cell carcinoma; protoporphyrin IX (PpIX); reactive oxygen species

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; COPROPORPHYRINOGEN OXIDASE; MESSENGER RNA; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AMINOLEVULINIC ACID; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL DEATH; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; MOUTH NEOPLASMS; PHOTOCHEMOTHERAPY; PROTOPORPHYRINS; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 78149376272     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21301     Document Type: Article

References (27)

1. Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB,. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 2006; 6: 1111-1118.
2. Mao L, Hong WK, Papadimitrakopoulou VA,. Focus on head and neck cancer. Cancer Cell 2004; 5: 311-316.
3. Hopper C, Kübler A, Lewis H, Tan IB, Putnam G,. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer 2004; 111: 138-146.
4. Frimberger AE, Moore AS, Cincotta L, Cotter SM, Foley JW,. Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer. Clin Cancer Res 1998; 4: 2207-2218.
5. Castano AP, Demidova TN, Hamblin MR,. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagn and Photodyn Ther 2004; 1: 279-293.
6. Kelty CJ, Brown NJ, Reed MW, Ackroyd R,. The use of 5-aminolevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis. Photochem Photobiol Sci 2002; 1: 158-168.
7. Sharma S, Jajoo A, Dube A,. 5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines. J Photochem Photobiol B 2007; 88: 156-162.
8. van den Akker JT, Iani V, Star WM, Sterenborg HJ, Moan J,. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol 2000; 72: 681-689.
9. Tsai T, Hong RL, Tsai JC, Lou PJ, Ling IF, Chen CT,. Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells. Lasers Surg Med 2004; 34: 62-72.
10. Wu RW, Chu ES, Yow CM, Chen JY,. Photodynamic effects on nasopharyngeal carcinoma (NPC) cells with 5-aminolevulinic acid or its hexyl ester. Cancer Lett 2006; 242: 112-119.
11. Gerscher S, Connelly JP, Griffiths J, et al. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. Photochem Photobiol 2000; 72: 569-574.
12. Marti A, Jichlinski P, Lange N, et al. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol 2003; 170 (2 Pt 1): 428-432.
13. Brunner H, Hausmann F, Knuechel R,. New 5-aminolevulinic acid esters-efficient protoporphyrin precursors for photodetection and photodynamic therapy. Photochem Photobiol 2003; 78: 481-486.
14. Perotti C, Fukuda H, DiVenosa G, MacRobert AJ, Batlle A, Casas A,. Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies. Br J Cancer 2004; 90: 1660-1665.
15. Wu SM, Ren QG, Zhou MO, Peng Q, Chen JY,. Protoporphyrin IX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevulinic acid and its hexylester. Cancer Lett 2003; 200: 123-131.
16. Lee JB, Choi JY, Chun JS, et al. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolevulinic acid and its esters on various cell lines derived from the skin. Br J Dermatol 2008; 159: 61-67.
17. Sinha AK, Anand S, Ortel BJ, et al. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer 2006; 95: 485-495.
18. Hsieh YJ, Wu CC, Chang CJ, Yu JS,. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J Cell Physiol 2003; 194: 363-375.
19. Lu Z, Tao Y, Zhou Z, et al. Mitochondrial reactive oxygen species and nitric oxide-mediated cancer cell apoptosis in 2-butylamino-2- demethoxyhypocrellin B photodynamic treatment. Free Radic Biol Med 2006; 41: 1590-1605.
20. Nowis D, Makowski M, Stokłosa T, Legat M, Issat T, Gołab J,. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol 2005; 52: 339-352.
21. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.
22. Cryns V, Yuan J,. Proteases to die for. Genes Dev 1998; 12: 1551-1570.
23. Le Rhun Y, Kirkland JB, Shah GM,. Cellular responses to DNA damage in the absence of Poly(ADP-ribose) polymerase. Biochem Biophys Res Commun 1998; 245: 1-10.
24. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
25. Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 1995; 81: 801-809.
26. Berger NA, Petzold SJ,. Identification of minimal size requirements of DNA for activation of poly(ADP-ribose) polymerase. Biochemistry 1985; 24: 4352-4355.
27. Berger NA,. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 1985; 101: 4-15.